Find comprehensive information on uterine polyp diagnosis, including clinical documentation, medical coding (ICD-10 N84.0, endometrial polyp), and healthcare guidance. Learn about polyp symptoms, treatment options, and the connection between uterine polyps and abnormal uterine bleeding. Explore resources for healthcare professionals, covering diagnostic criteria, hysteroscopy procedures, and pathology reports. This resource provides essential information for accurate uterine polyp diagnosis and management.
Also known as
Uterine polyps
Polyps of the uterine body, including the cervix.
Polyp of female genital tract
Polyps affecting various parts of the female genital tract.
Inflammatory diseases of uterus
Inflammation and related conditions of the uterus, sometimes linked to polyp formation.
Leiomyoma of uterus
Benign uterine tumors (fibroids) which can be mistaken for or co-occur with polyps.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the uterine polyp endometrial?
When to use each related code
| Description |
|---|
| Uterine Polyp |
| Endometrial Hyperplasia |
| Submucosal Fibroid |
Coding lacks specificity (e.g., endometrial vs. cervical). Impacts DRG assignment and reimbursement. CDI query needed.
Missing polyp size affects accurate coding selection (e.g., N84.0 vs. D28.0). Impacts quality metrics.
Inconsistent documentation of atypia (e.g., with/without atypia) can lead to upcoding/downcoding risks.
Q: What are the most effective diagnostic strategies for differentiating between benign uterine polyps and endometrial hyperplasia or malignancy in premenopausal women?
A: Differentiating benign uterine polyps from endometrial hyperplasia or malignancy in premenopausal women requires a multi-faceted approach. Transvaginal ultrasound, while helpful for initial assessment, often lacks the specificity to definitively rule out malignancy. Hysteroscopy with directed biopsy remains the gold standard for diagnosis. Sonohysterography can enhance the sensitivity of ultrasound, particularly for evaluating intracavitary lesions. Consider implementing endometrial sampling, either via Pipelle biopsy or during hysteroscopy, for definitive histopathological evaluation. This is crucial for accurately characterizing the lesion and guiding appropriate management. Explore how risk factors such as age, obesity, and abnormal bleeding patterns influence the diagnostic workup.
Q: How should asymptomatic uterine polyps discovered incidentally during routine pelvic ultrasound in postmenopausal women be managed, considering potential risks and benefits of intervention?
A: Managing asymptomatic uterine polyps found incidentally in postmenopausal women involves careful consideration of risks and benefits. While most polyps are benign, the risk of malignancy increases with age. Factors such as polyp size, patient symptoms (even if subtle), and patient preference play a role in decision-making. For small, asymptomatic polyps, expectant management with periodic ultrasound surveillance may be appropriate. However, for larger polyps (especially >1.5 cm) or those with concerning ultrasound features, hysteroscopic removal with histopathological evaluation is generally recommended. Learn more about the current guidelines and best practices for managing asymptomatic uterine polyps in postmenopausal women to ensure optimal patient care.
Patient presents with abnormal uterine bleeding, including menorrhagia, metrorrhagia, and intermenstrual bleeding. The patient reports heavy menstrual periods and irregular bleeding between cycles. Physical examination revealed no abnormalities other than the reported bleeding pattern. Transvaginal ultrasound revealed an endometrial polyp measuring 1.5 cm within the uterine cavity. Differential diagnosis includes endometrial hyperplasia, submucosal fibroids, and endometrial cancer. Based on the ultrasound findings and patient symptoms, a diagnosis of uterine polyp is made. Plan includes hysteroscopy with polypectomy for definitive diagnosis and treatment. Procedure risks and benefits were discussed with the patient, and informed consent was obtained. Follow-up appointment scheduled for post-operative evaluation and discussion of pathology results. Medical coding includes ICD-10 code N84.0 for uterine polyp and CPT code 58558 for hysteroscopy with polypectomy. This documentation supports medical necessity for the procedure and facilitates accurate billing and reimbursement.